Use of agonists of the peroxisome proliferator activated receptor alpha for treating obesity
US6028109A · kind A · utility
31Cited by
0References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 28, 1998 |
| Grant date | Feb 22, 2000 |
| Priority date | — |
| Expiry date | Sep 28, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of agonists of the peroxisome proliferator activated receptor alpha (PPAR.alpha.) for the manufacture of a medicament for the treatment of obesity and methods of treating obesity comprising the administration of a therapeutic amount of a PPAR.alpha. agonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.